Purpose: Like cancer cells, photoreceptor cells produce lactate aerobically, requiring lactate dehydrogenase A (LDH-A). Cancer cells also use glycolytic intermediates for biosynthesis. The molecular switch controlling glycolytic flow is thought to be an isoenzyme of pyruvate kinase (PKM2). Here, we determined the expression and localization of PKM2 and LDH-A in mammalian retina and make comparisons with the brain. Methods: Single- and double-labeling immunohistochemistry for PKM2, pyruvate kinase M1 (PKM1), and LDH-A were performed using retinal sections from C57BL/6 mice, Sprague-Dawley rats, rabbits, marmosets, and humans. Pyruvate kinase M1 and PKM2 mRNA and protein expression levels were quantified in rodent retina and brain by using qPCR and immunoblotting. The quaternary forms of PKM2 in rat retina were also determined. Results: Pyruvate kinase M2 was present in some glial cells and rod and cone photoreceptors in the retina of all species but was exclusively localized to glia in the brain. Pyruvate kinase M1 was confined to neurons in the retina and brain. Lactate dehydrogenase A was principally found in photoreceptors and inner portion of the avascular rabbit retina. Western blotting and qPCR confirmed high levels of PKM2 and LDH-A in the retina. There was a 6- to 9-fold greater expression of PKM2 mRNA in the rodent retina than in the brain. Both the dimeric (inactive, biosynthesis-driving form) and the active tetrameric (glycolytic-driving) forms of PKM2 were present in retina but not in brain. Conclusions: Mammalian photoreceptors contain dimeric and tetrameric PKM2 and LDH-A. This is consistent with the ability to switch between energy production and biosynthesis like a proliferating tissue, possibly due to demands of opsin synthesis.
1 September 2014 in Investigative Ophthalmology & Visual Science
Purpose. Both mitochondrial dysfunction and endoplasmic reticulum (ER) stress have been implicated in the pathogenesis of neurodegenerative disorders. The purpose of the present study was to investigate the mechanisms of cellular damage resulting from mitochondrial dysfunction induced in cultured retinal cells and, in particular, whether ER stress plays a role in this response. Methods. Mixed retinal cell cultures containing neurons and glia were prepared from neonatal rats. The complex I inhibitor rotenone was employed to induce mitochondrial dysfunction. Immunocytochemistry, Western blotting, and assays for reactive oxygen species (ROS), adenosine triphosphate (ATP), and TdT-dUTP terminal nick-end labeling (TUNEL) were used as standard to elucidate cellular responses. Results. Neurons were more rapidly affected by rotenone (1 μM) than glial cells, with significant loss of these cells appearing by 6 hours after application. Glial death was apparent by 24 hours and was associated with positive nuclear labeling by TUNEL. All cell loss was associated with increased ROS production, but neuronal loss was also concurrent with a significant depletion in cellular ATP. Increased expression of the characteristic ER stress components immunoglobulin heavy-chain binding protein (BiP), ATF-4 (activating transcription factor 4), phospho-PERK (pancreatic endoplasmic reticulum kinase/PKR-like endoplasmic reticulum kinase), and growth arrest and DNA damage-inducible protein/C/EBP homologous protein (CHOP) was evident in the rotenone-treated cultures after 6 hours in glial cells. Furthermore, inhibition of glycogen synthase kinase-3β (GSK-3β) with LiCl was able to protect glia cells, whereas inhibition of the calpain with calpain inhibitor III protected only neurons. Conclusions. These data together demonstrate that a mitochondrial dysfunction induced in retinal cells can give rise to pathology via a variety of mechanisms including ATP depletion, ROS elevation, ER stress, or activation of GSK-3β or calpain. Such mechanisms predominantly depend upon the concentration and duration of mitochondrial challenge and the type of cell affected.